The Impact of Hypoglycemic Therapy on the Prognosis for Acute Coronary Syndrome in Patients with Type 2 Diabetes
Open Access
- 22 May 2022
- journal article
- review article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (5) , 845
Abstract
The article discusses particular circumstances of acute coronary syndrome (ACS) in patients with type 2 diabetes (T2D). In addition, the available literature data and clinical guidelines reflecting the role of hypoglycemic therapy as a cardioprotection factor in ACS are analyzed. The article considers possible protective molecular mechanisms of various groups of drugs in ischemic cardiomyocytes.Keywords
Funding Information
- the Russian state-funded project for Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences (121031300045-2, 122031700094-5)
- Research Institute of Internal and Preventive Medicine—Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (121031300045-2, 122031700094-5)
This publication has 61 references indexed in Scilit:
- Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndromeDiabetes & Metabolism, 2012
- Prognostic Value of Admission Glycosylated Hemoglobin and Glucose in Nondiabetic Patients With ST-Segment–Elevation Myocardial Infarction Treated With Percutaneous Coronary InterventionCirculation, 2011
- The role of insulin therapy and glucose normalisation in patients with acute coronary syndromeNetherlands Heart Journal, 2011
- Glycaemic control in acute coronary syndromes: prognostic value and therapeutic optionsEuropean Heart Journal, 2010
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- Hyperglycemia and Acute Coronary SyndromeAnesthesiology, 2008
- Glucometrics in Patients Hospitalized With Acute Myocardial InfarctionCirculation, 2008
- The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetesThe Lancet, 2006
- U-Shaped Relationship of Blood Glucose With Adverse Outcomes Among Patients With ST-Segment Elevation Myocardial InfarctionJACC, 2005
- Feasibility of Insulin-Glucose Infusion in Diabetic Patients With Acute Myocardial Infarction: A report from the multicenter trial: DIGAMIDiabetes Care, 1994